Abstract
The World Health Organization (WHO) report on “Neurological disorders: Public health challenges” (2006), a collaborative international survey involved 109 countries. Its projection reveals one billion population to be affected globally by 2030. The advent of nanotherapeutics has significantly leveraged the field of therapeutics with the development of nanosized materials in biomedical diagnosis and therapy of neurological diseases/disorders (ND) specifically.
The inclusion of functional nanomaterials includes polymeric nanomaterials (micelle, nano-capsule, and dendrimer) and lipid-based nanoparticles (solid lipid nanoparticle and liposomes) as deliverables at the cellular and molecular levels. It has led to concerted progress in recent approaches to molecular diagnosis, gene/drug delivery, and combinatorial therapy. In this chapter, we will orient the progress and advancements in the novel approaches of nanomaterials as nanotherapeutics in the diagnosis, management, inhibition, and prospects of varied nanomaterials in the diverse application of nanomedicines in ND.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal M, Kumar S (2022) The use of nanorobotics in the treatment therapy of cancer and its future aspects: a review. Cureus 14(9):e29366. https://doi.org/10.7759/cureus.29366
Aigner A, Kögel D (2018) Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs? Nanomedicine 13(1):89–103
Ameri M, Shabaninejad Z, Movahedpour A, Sahebkar A, Mohammadi S, Hosseindoost S et al (2020) Biosensors for detection of tau protein as an Alzheimer’s disease marker. Int J Biol Macromol 162:1100–1108. https://doi.org/10.1016/j.ijbiomac.2020.06.239
Amirifar L, Shamloo A, Nasiri R, de Barros NR, Wang ZZ, Unluturk BD et al (2022) Brain-on-a-chip: recent advances in design and techniques for microfluidic models of the brain in health and disease. Biomaterials 285:121531. https://doi.org/10.1016/j.biomaterials.2022.121531
Ashrafizadeh M, Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Raei M et al (2021) Hyaluronic acidbased nanoplatforms for doxorubicin: a review of stimuli-responsive carriers, co-delivery and resistance suppression. Carbohydr Polym 272:118491. https://doi.org/10.1016/j.carbpol.2021.118491
Avasthi A, Caro C, Pozo-Torres E, Leal MP, García-Martín ML (2020) Magnetic nanoparticles as MRI contrast agents. Top Curr Chem 378(3):40. https://doi.org/10.1007/s41061-020-00302-w
Baboota S, Ali J (2020) Nanotherapeutics for neurological disorders. Curr Pharm Des 26(19):2193–2194. https://doi.org/10.2174/138161282619200520074049
Bang S, Lee S, Choi N, Kim HN (2021) Emerging brain-pathophysiology-mimetic platforms for studying neurodegenerative diseases: brain organoids and brains-on-a-chip. Adv Healthc Mater 10(12):e2002119. https://doi.org/10.1002/adhm.202002119
Batool S, Nabipour H, Ramakrishna S, Mozafari M (2022) Nanotechnology and quantum science enabled advances in neurological medical applications: diagnostics and treatments. Med Biol Eng Comput 60(12):3341–3356. https://doi.org/10.1007/s11517-022-02664-3
Berners-Price SJ, Filipovska A (2011) Gold compounds as therapeutic agents for human diseases. Metallomics 3:863–873. https://doi.org/10.1039/c1mt00062d
Caro C, Avasthi A, Paez-Muñoz JM, Leal MP, García-Martín ML (2021) Passive targeting of high-grade gliomas via the EPR effect: a closed path for metallic nanoparticles? Biomater Sci 9(23):7984–7995. https://doi.org/10.1039/D1BM01398J
Catalan-Figueroa J, Morales JO (2021) Safety and nanotoxicity aspects of nanomedicines for brain-targeted drug delivery. Nanomedicines for Brain Drug Delivery 255-277. https://doi.org/10.1007/978-1-0716-0838-8_10
Chainoglou E, Hadjipavlou-Litina D (2020) Curcumin in health and diseases: Alzheimer’s disease and curcumin analogues, derivatives, and hybrids. Int J Mol Sci 21(6):1975. https://doi.org/10.3390/ijms21061975
Chaudhary V (2022) Prospects of green nanotechnology for efficient management of neurodegenerative diseases. Front Nanotechnol 4:1055708. https://doi.org/10.3389/fnano.2022.1055708
Chaudhary V et al (2023) Biogenic green metal nano systems as efficient anti-cancer agents. Environ Res 229:115933. https://doi.org/10.1016/j.envres.2023.115933
Cheng Z, Li M, Dey R, Chen Y (2021) Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol 14(1):1–27. https://doi.org/10.1186/s13045-021-01096-0
Clausen T (2003) Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83(4):1269–1324. https://doi.org/10.1152/physrev.00011.2003
Deore MS, Raza SS, Naqvi S (2022) Insights into therapeutic targets in stroke. In: Regenerative therapies in ischemic stroke recovery. Springer Nature Singapore, Singapore, pp 293–316. https://doi.org/10.1007/978-981-16-8562-0_12
Di Pietro P, Strano G, Zuccarello L, Satriano C (2016) Gold and silver nanoparticles for applications in theranostics. Curr Top Med Chem 16(27):3069–3102
Ding F, O’Donnell J, Xu Q, Kang N, Goldman N, Nedergaard M (2016) Changes in the composition of brain interstitial ions control the sleep-wake cycle. Science 352(6285):550–555. https://doi.org/10.1126/science.aad4821
Egelman DM, Montague PR (1999) Calcium dynamics in the extracellular space of mammalian neural tissue. Biophys J 76(4):1856–1867. https://doi.org/10.1016/S0006-3495(99)77345-5
Fang C, Wang K, Stephen ZR, Mu Q, Kievit FM, Chiu DT et al (2015) Temozolomide nanoparticles for targeted glioblastoma therapy. ACS Appl Mater Interfaces 7(12):6674–6682. https://doi.org/10.1021/am5092165
Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M et al (2020) The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 19(3):255–265. https://doi.org/10.1016/S1474-4422(19)30411-9
Feng Z, Ma Y, Li B, He L, Wang Q, Huang J et al (2019) Mitochondria targeted self-assembled ratiometric fluorescent nanoprobes for pH imaging in living cells. Anal Methods 11(15):2097–2104. https://doi.org/10.1039/C9AY00473D
Gautam A et al (2022) Towards modern-age advanced sensors for the management of neurodegenerative disorders: current status, challenges and prospects. ECS Sensor Plus 1:042401. https://doi.org/10.1149/2754-2726/ac973e
Ghosh S et al (2022) Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease. Carbon Lett 32:1381–1394. https://doi.org/10.1007/s42823-022-00397-9
Hanif S, Muhammad P, Niu Z, Ismail M, Morsch M, Zhang X et al (2021) Nanotechnology-based strategies for early diagnosis of central nervous system disorders. Adv NanoBiomed Res 1(10):2100008. https://doi.org/10.1002/anbr.202100008
Hasannejad-Asl B, Pooresmaeil F, Choupani E, Dabiri M, Behmardi A, Fadaie M et al (2023) Nanoparticles as powerful tools for crossing the blood-brain barrier. CNS Neurol Disord Drug Targets 22(1):18–26. https://doi.org/10.2174/1871527321666220222092655
He L, Huang G, Liu H, Sang C, Liu X, Chen T (2020) Highly bioactive zeolitic imidazolate framework-8–capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke. Sci Adv 6(12):eaay9751. https://doi.org/10.1126/sciadv.aay9751
He SB, Lin MT, Deng HH, Chen W (2022) Cupric oxide Nanozymes for biomedical applications. In: Nanozymes: design, synthesis, and applications. American Chemical Society, pp 117–133. https://doi.org/10.1021/bk-2022-1422.ch005
Hsu JF, Chu SM, Liao CC, Wang CJ, Wang YS, Lai MY et al (2021) Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: an update. Cancers 13(2):195. https://doi.org/10.3390/cancers13020195
Hu H, Chen X, Zhao K, Zheng W, Gao C (2023) Recent advances in biomaterials-based therapies for alleviation and regeneration of traumatic brain injury. Macromol Biosci 23:e2200577. https://doi.org/10.1002/mabi.202200577
Karim R, Palazzo C, Evrard B, Piel G (2016) Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art. J Control Release 227:23–37. https://doi.org/10.1016/j.jconrel.2016.02.026
Kaur I, Kumar A, Behl T, Setia D (2021) Recent advances in nanotechnology-based drug delivery approaches for Alzheimer disease. Curr Drug Targets 22(12):1404–1423. https://doi.org/10.2174/1389450122999210104205018
Kaushik A, Jayant RD, Nair M (eds) (2017) Advances in personalized nanotherapeutics. Springer International Publishing, New York
Kumar R, Aadil KR, Ranjan S, Kumar VB (2020) Advances in nanotechnology and nanomaterials-based strategies for neural tissue engineering. J Drug Deliv Sci Technol 57:101617. https://doi.org/10.1016/j.jddst.2020.101617
Lee LKC, Leong LI, Liu Y, Luo M, Chan HYE, Choi CHJ (2020) Preclinical nanomedicines for polyglutamine-based neurodegenerative diseases. Mol Pharm 18(2):610–626. https://doi.org/10.1021/acs.molpharmaceut.0c00506
Li L, He R, Yan H, Leng Z, Zhu S, Gu Z (2022) Nanotechnology for the diagnosis and treatment of Alzheimer’s disease: a bibliometric analysis. Nano Today 47:101654. https://doi.org/10.1016/j.nantod.2022.101654
Li A, Tyson J, Patel S, Patel M, Katakam S, Mao X, He W (2021) Emerging nanotechnology for treatment of Alzheimer’s and Parkinson’s disease. Front Bioeng Biotechnol 322. https://doi.org/10.1007/s00441-014-1819-7
Ling TS, Chandrasegaran S, Xuan LZ, Suan TL, Elaine E, Nathan DV et al (2021) The potential benefits of nanotechnology in treating Alzheimer’s disease. Biomed Res Int. https://doi.org/10.1155/2021/5550938
Liu Z, Gao X, Kang T, Jiang M, Miao D, Gu G et al (2013) B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide. Bioconjug Chem 24(6):997–1007. https://doi.org/10.1021/bc400055h
Liu R, Feng ZY, Li D, Jin B, Lan Y, Meng LY (2022) Recent trends in carbon-based microelectrodes as electrochemical sensors for neurotransmitter detection: a review. TrAC Trends Anal Chem 148:116541. https://doi.org/10.1016/j.trac.2022.116541
Lowe TL, Agrahari V, Kannan RM, Kannan S (2019) Nanotechnology enabled regenerative medicine for neurological disorders. Adv Drug Deliv Rev 148:1. https://doi.org/10.1016/j.addr.2019.11.006
McClements J, McClements DJ (2016) Standardization of nanoparticle characterization: methods for testing properties, stability, and functionality of edible nanoparticles. Crit Rev Food Sci Nutr 56(8):1334–1362. https://doi.org/10.1080/10408398.2014.970267
Mohi-ud-Din R, Mir RH, Mir PA, Banday N, Shah AJ, Sawhney G et al (2022) Dysfunction of ABC transporters at the surface of BBB: potential implications in intractable epilepsy and applications of nanotechnology enabled drug delivery. Curr Drug Metab 23(9):735–756. https://doi.org/10.2174/1389200223666220817115003
Nair M, Jayant RD, Kaushik A, Sagar V (2016) Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev 103:202–217. https://doi.org/10.1016/j.addr.2016.02.008
Naqvi S, Panghal A, Flora SJS (2020) Nanotechnology: a promising approach for delivery of neuroprotective drugs. Front Neurosci 14:494. https://doi.org/10.3389/fnins.2020.00494
Nguyen TT, Nguyen TTD, Vo TK, Nguyen MK, Van Vo T, Van Vo G (2021) Nanotechnology-based drug delivery for central nervous system disorders. Biomed Pharmacother 143:112117. https://doi.org/10.1016/j.biopha.2021.112117
Nikita et al (2023) Cancer treatment and toxicity outlook of nanoparticles. Environ Res 237(1):116870. https://doi.org/10.1016/j.envres.2023.116870
Pada AK, Desai D, Sun K, Prakirth Govardhanam N, Törnquist K, Zhang J, Rosenholm JM (2019) Comparison of polydopamine-coated mesoporous silica nanorods and spheres for the delivery of hydrophilic and hydrophobic anticancer drugs. Int J Mol Sci 20(14):3408. https://doi.org/10.3390/ijms20143408
Palmieri M, Pozzer D, Landsberger N (2023) Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives. Front Neurosci 17:1172805. https://doi.org/10.3389/fnins.2023.1172805
Panda MK, Panda SK, Singh YD, Jit BP, Behara RK, Dhal NK (2020) Role of nanoparticles and nanomaterials in drug delivery: an overview. In: Advances in pharmaceutical biotechnology: recent progress and future applications, pp 247–265. https://doi.org/10.1007/978-981-15-2195-919
Park J, Lee BK, Jeong GS, Hyun JK, Lee CJ, Lee SH (2015) Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer’s disease. Lab Chip 15(1):141–150
Parvez S, Kaushik M, Ali M, Alam MM, Ali J, Tabassum H, Kaushik P (2022) Dodging blood brain barrier with “nano” warriors: novel strategy against ischemic stroke. Theranostics 12(2):689. https://doi.org/10.7150/thno.64806
Peng J, Feng L-N, Zhang K, Li X-H, Jiang L-P, Zhu J-J (2012) Calcium carbonate-gold nanocluster hybrid spheres: synthesis and versatile application in immunoassays. Chem Eur J 18:5261–5268. https://doi.org/10.1002/chem.201102876
Pichla M, Bartosz G, Sadowska-Bartosz I (2020) The antiaggregative and antiamyloidogenic properties of nanoparticles: a promising tool for the treatment and diagnostics of neurodegenerative diseases. Oxidative Med Cell Longev. https://doi.org/10.1155/2020/3534570
Qian X, Xu Z (2015) Fluorescence imaging of metal ions implicated in diseases. Chem Soc Rev 44(14):4487–4493. https://doi.org/10.1039/C4CS00292J
Rempe R, Cramer S, Qiao R, Galla HJ (2014) Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties. Cell Tissue Res 355:717–726. https://doi.org/10.1007/s00441-014-1819-7
Richards DG, McMillin DL, Mein EA, Nelson CD (2002) Gold and its relationship to neurological/glandular conditions. Int J Neurosci 112:31–53. https://doi.org/10.1080/00207450212018
Rusakov DA (2012) Depletion of extracellular Ca2+ prompts astroglia to moderate synaptic network activity. Sci Signal 5(208):pe4. PMID: 22275219. https://doi.org/10.1126/scisignal.2002799
Saha S, Prakash V, Halder S, Chakraborty K, Krishnan Y (2015) A pH-independent DNA nanodevice for quantifying chloride transport in organelles of living cells. Nat Nanotechnol 10(7):645–651. PMID: 26098226. https://doi.org/10.1038/nnano.2015.130
Sangubotla R, Kim J (2018) Recent trends in analytical approaches for detecting neurotransmitters in Alzheimer’s disease. TrAC Trends Anal Chem 105:240–250. https://doi.org/10.1016/j.trac.2018.05.014
Sayad A, Uddin SM, Yao S, Wilson H, Chan J, Zhao H et al (2022) A magnetoimpedance biosensor microfluidic platform for detection of glial fibrillary acidic protein in blood for acute stroke classification. Biosens Bioelectron 211:114410. https://doi.org/10.1016/j.bios.2022.114410
Sharma G, Sharma AR, Lee SS, Bhattacharya M, Nam JS, Chakraborty C (2019) Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm 559:360–372. https://doi.org/10.1016/j.ijpharm.2019.01.056
Sharma S, Rabbani SA, Agarwal T, Baboota S, Pottoo FH, Kadian R (2021) Nanotechnology driven approaches for the management of Parkinson’s disease: current status and future perspectives. Curr Drug Metab 22(4):287–298. https://doi.org/10.2174/1389200221666201124123405
Singh TA, Das J, Sil PC (2020) Zinc oxide nanoparticles: a comprehensive review on its synthesis, anticancer and drug delivery applications as well as health risks. Adv Colloid Interf Sci 286:102317. https://doi.org/10.1016/j.cis.2020.102317
Sun H, Gong TT, Jiang YT, Zhang S, Zhao YH, Wu QJ (2019) Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990–2017: results from a global burden of disease study, 2017. Aging (Albany NY) 11(23):10952. https://doi.org/10.18632/aging.102497
Tiwari JN, Tiwari RN, Kim KS (2012) Zero-dimensional, one-dimensional, two-dimensional and three-dimensional nanostructured materials for advanced electrochemical energy devices. Prog Mater Sci 57(4):724–803. https://doi.org/10.1016/j.pmatsci.2011.08.003
Valadão KMG, Luizeti BO, Yamaguchi MU, Issy AC, Bernuci MP (2022) Nanotechnology in improving the treatment of Huntington’s disease: a systematic review. Neurotox Res 40(2):636–645. https://doi.org/10.1007/s12640-021-00468-1
Vashist A, Manickam P, Raymond AD, Arias AY, Kolishetti N, Vashist A et al (2023) Recent advances in nanotherapeutics for neurological disorders. ACS Applied Bio Materials 6(7):2614–2621. https://doi.org/10.1021/acsabm.3c00254
Wang J, Wang P, Zhao Q, Yu T, Du X, Hao X et al (2020a) Highly dispersed Ag nanoparticles embedded on the surface of CeO2/CF nanowires derived from three-dimensional structured Cu foam for toluene catalytic oxidation. Mol Catal 486:110879. https://doi.org/10.1016/j.mcat.2020.110879
Wang Y, An L, Lin J, Tian Q, Yang S (2020b) A hollow Cu9S8 theranostic nanoplatform based on a combination of increased active sites and photothermal performance in enhanced chemodynamic therapy. Chem Eng J 385:123925. https://doi.org/10.1016/j.cej.2019.123925
Wang Q, Jiang J, Gao L (2021) Nanozyme-based medicine for enzymatic therapy: progress and challenges. Biomed Mater 16(4):042002. https://doi.org/10.1088/1748-605X/abe7b4
Wang J, Wang L, Su X, Chen R (2022) Bandgap engineering of CdTe/CdSe rod-shaped core/shell and CdTeSe ellipsoidal alloy quantum dots with tunable and intense emission. J Alloys Compd 920:165907. https://doi.org/10.1016/j.jallcom.2022.165907
Wei M, Lin P, Chen Y, Lee JY, Zhang L, Li F, Ling D (2020) Applications of ion level nanosensors for neuroscience research. Nanomedicine 15(29):2871–2881. https://doi.org/10.2217/nnm-2020-0320
WHO (2006) Neurological disorders: public health challenges. WHO
Wu L, Liu G, Wang W, Liu R, Liao L, Cheng N et al (2020a) Cyclodextrin-modified CeO2 nanoparticles as a multifunctional nanozyme for combinational therapy of psoriasis. Int J Nanomedicine 15:2515–2527. https://doi.org/10.2147/IJN.S246783
Wu CY, Huang RY, Liao EC, Lin YC, Ho YJ, Chang CW et al (2020b) A preliminary study of Parkinson’s gene therapy via sono-magnetic sensing gene vector for conquering extra/intracellular barriers in mice. Brain Stimul 13(3):786–799. https://doi.org/10.1016/j.brs.2020.02.024
Yadav D, Nara S (2022) Nanozymes for neurodegenerative diseases. In: Conference BioSangam 2022: emerging trends in biotechnology (BIOSANGAM 2022). Atlantis Press, pp 77–95. https://doi.org/10.2991/978-94-6463-020-6_9
Yellen G (2002). PMID: 12214225) The voltage-gated potassium channels and their relatives. Nature 419(6902):35–42. https://doi.org/10.1038/nature00978
Yin J, Hu Y, Yoon J (2015) Fluorescent probes and bioimaging: alkali metals, alkaline earth metals and pH. Chem Soc Rev 44(14):4619–4644. https://doi.org/10.1039/C4CS00275J
Yue M, Guo T, Nie DY, Zhu YX, Lin M (2023) Advances of nanotechnology applied to cancer stem cells. World Journal of Stem Cells 15(6):514. https://doi.org/10.4252/wjsc.v15.i6.514
Zahir-Jouzdani F, Mottaghitalab F, Dinarvand M, Atyabi F (2018) siRNA delivery for treatment of degenerative diseases, new hopes and challenges. J Drug Deliv Sci Technol 45:428–441. https://doi.org/10.1016/j.jddst.2018.04.001
Zhang Y, Liu W, Wang X, Liu Y, Wei H (2023) Nanozyme-enabled treatment of cardio-and cerebrovascular diseases. Small 19(13):2204809. https://doi.org/10.1002/smll.202204809
Zhang W, Sigdel G, Mintz KJ, Seven ES, Zhou Y, Wang C, Leblanc RM (2021a) Carbon dots: a future blood–brain barrier penetrating nanomedicine and drug nanocarrier. Int J Nanomedicine 16:5003. https://doi.org/10.2147/IJN.S318732
Zhang Y, Yang H, Wei D, Zhang X, Wang J, Wu X, Chang J (2021b) Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases. Exploration 1(3):20210115. https://doi.org/10.1002/EXP.20210115
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ravindranath, B.S., Grewall, A. (2023). Nanotherapeutics for Neurological Disorders. In: Gautam, A., Chaudhary, V. (eds) Theranostic Applications of Nanotechnology in Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-9510-3_5
Download citation
DOI: https://doi.org/10.1007/978-981-99-9510-3_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-9509-7
Online ISBN: 978-981-99-9510-3
eBook Packages: MedicineMedicine (R0)